A comparision between of Donepezil vs. Donepezil and Trazodonee efficacy in the cognitive impairment among elderly Patients with Dementia

Phase 1

Recruiting

• Conditions: Cognitive impairment.; G31.84; Mild cognitive impairment, so stated

• Registration Number: IRCT20190317043079N1
• Lead Sponsor: Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Elderly patients with dementia

Exclusion Criteria

History of diabetes, blood pressure, thyroid problem, and reversible dementia

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of cognitive impairment. Timepoint: Before starting treatment and six months after starting treatment. Method of measurement: mini mental status exam(MMSE) questionnaire.

Secondary Outcome Measures

Name	Time	Method
Sevirity of Cognitive impairment. Timepoint: Before starting treatment and six months after starting treatment. Method of measurement: Addenbrooke's cognitive examination questionnaire.